Abstract
Bentham Science Publishers would like to thank and appreciate the co-operation from all reviewers (Editorial Board & External Reviewers) for their constructive comments and feedback on the manuscripts submitted to Recent Patents on Inflammation & Allergy Drug Discovery. Their efforts have contributed greatly to the high quality and continuous growth of the journal. Given below is the list of reviewers who reviewed articles received for the Journal during 2011-2012:.....
Recent Patents on Inflammation & Allergy Drug Discovery
Title:Acknowledgment to Reviewers
Volume: 6 Issue: 3
Author(s): Bentham Science Publishers
Affiliation:
Abstract: Bentham Science Publishers would like to thank and appreciate the co-operation from all reviewers (Editorial Board & External Reviewers) for their constructive comments and feedback on the manuscripts submitted to Recent Patents on Inflammation & Allergy Drug Discovery. Their efforts have contributed greatly to the high quality and continuous growth of the journal. Given below is the list of reviewers who reviewed articles received for the Journal during 2011-2012:.....
Export Options
About this article
Cite this article as:
Science Publishers Bentham, Acknowledgment to Reviewers, Recent Patents on Inflammation & Allergy Drug Discovery 2012; 6 (3) . https://dx.doi.org/10.2174/187221312802652866
DOI https://dx.doi.org/10.2174/187221312802652866 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
Related Articles
-
Molecular Signature of Human amniotic Fluid Stem Cells During Fetal Development
Current Stem Cell Research & Therapy Long-Term Benefits of Nevirapine-Containing Regimens: Multicenter Study with 506 Patients, Followed-Up a Median of 9 Years
Current HIV Research Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets Heme Oxygenase-1 in Vascular Smooth Muscle Cells Counteracts Cardiovascular Damage Induced by Angiotensin II
Current Neurovascular Research Signal Transduction through JAK-STAT and NF-κB Regulated Pim-1 Kinase: Novel Target for Anticancer Leads
Current Signal Transduction Therapy Neuroinflammation and Immunity: A New Pharmacological Target in Depression
CNS & Neurological Disorders - Drug Targets Overlooked Issues of Snakebite Management: Time for Strategic Approach
Current Topics in Medicinal Chemistry Lipotoxicity on the Basis of Metabolic Syndrome and Lipodystrophy in HIV-1-Infected Patients Under Antiretroviral Treatment
Current Pharmaceutical Design Pexelizumab and its Role in the Treatment of Myocardial Infarction and in Coronary Artery Bypass Graft Surgery: A Review
Recent Patents on Cardiovascular Drug Discovery Diabetes of the Brain: Computational Approaches and Interventional Strategies
CNS & Neurological Disorders - Drug Targets Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer
Current Medicinal Chemistry Long-Chain Omega-3 Fatty Acid Deficiency in Mood Disorders: Rationale for Treatment and Prevention
Current Drug Discovery Technologies Patent Selections
Recent Patents on Anti-Infective Drug Discovery Renal Ischemia: How Commonly Does it Cause Renal Failure?
Current Hypertension Reviews The Use of Naltrexone in Dermatology. Current Evidence and Future Directions
Current Drug Targets Diclofenac 1,3,4-Oxadiazole Derivatives; Biology-Oriented Drug Synthesis (BIODS) in Search of Better Non-Steroidal, Non-Acid Antiinflammatory Agents
Medicinal Chemistry Homogeneous Time Resolved Fluorescence Assay to Measure Histamine Release
Combinatorial Chemistry & High Throughput Screening Editorial (Thematic Issue: The Monocyte/Macrophage in the Pathogenesis of AIDS: The Next Frontier for Therapeutic Intervention in the CNS and Beyond: Part I)
Current HIV Research Are Surgical Rates Decreasing in the Biological Era In IBD?
Current Drug Targets Animal Models of Depressive Illness: The Importance of Chronic Drug Treatment
Current Pharmaceutical Design